The global nuclear imaging equipment market is predicted to demonstrate rapid advancement in the coming years. Nuclear imaging procedures are painless and non-invasive medical tests that help healthcare practitioners diagnose the medical conditions of patients. Nuclear imaging involves the use of radioisotopes that are directly administered into the bloodstream, inhaled, or swallowed for providing images of how the organs and tissues function. Radioisotopes emit radiations that are used for diagnosing cancer and evaluating organ disorders.
Access Report Summary - Nuclear Imaging Equipment Market Segmentation Analysis
The rising incidence of cancer and the surging population of geriatric people are the major factors propelling the advancement of the nuclear imaging equipment market across the globe. As per the International Agency for Research on Cancer (IARC), which is a specialized cancer agency of the World Health Organization (WHO), nearly 12.7 million new patients were diagnosed with cancer all over the world in 2008 and this number will rise to 21.4 million by 2030.
Furthermore, in 2012, 8.2 million people lost their lives around the world because of cancer. Out of these deaths, lung cancer was responsible for the deaths of 1.6 million people, while, live cancer claimed the lives of 745,000 people. Moreover, as many as 400,000 people lost their lives because of esophageal cancer in 2012. The rapidly surging pool of people undergoing cancer screening and cancer diagnostic tests is positively impacting the demand for nuclear imaging equipment across the world.
Furthermore, the share of geriatric people in the global population will reach 21.1% by the end of 2050. When application is taken into consideration, the nuclear imaging equipment market is categorized into cardiology, oncology, and neurology. Amongst these, the oncology category recorded the highest growth in the market in the past, as per the observations of the market research company, P&S Intelligence. The market is also divided, depending on end user, into research institutes, hospitals, and diagnostic centers.
